Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/24 21:39 | 9/24/24 | HWH | RlEst | RlEst | Real Estate | Chan Heng Fai Ambrose | U0 | DOT | CEO | P | 3,802 | 0.6300 | 0 | 6,035 | 46 | 19,265 | I | ||||||||||||||
1/12/24 12:04 | 1/10/24 | ACAX | Retail | WhDrg | Drugs, Proprietaries & Druggi | Wolverine Asset Management LLC | IL | H | Former 1 | P | 2,134 | 10.66 | 0 | 200 | 0 | I | |||||||||||||||
12/13/23 17:03 | 8/25/23 | ACAX | Retail | WhDrg | Drugs, Proprietaries & Druggi | Yakira Capital Management, Inc. | CT | T | S.m | -779 | 11.02 | 0 | -71 | -20 | 279 | I | |||||||||||||||
12/4/23 21:30 | 11/30/23 | ACAX | Retail | WhDrg | Drugs, Proprietaries & Druggi | Chan Heng Fai Ambrose | U0 | DOT | CEO | S | -428 | 10.60 | 0 | -40 | -8 | 485 | I | ||||||||||||||
8/7/23 18:24 | 8/3/23 | ACAX | Retail | WhDrg | Drugs, Proprietaries & Druggi | Chan Heng Fai Ambrose | U0 | DOT | CEO | P.m | 248 | 7.67 | 0 | 32 | 6 | 539 | M | ||||||||||||||
8/3/23 12:34 | 8/2/23 | ACAX | Retail | WhDrg | Drugs, Proprietaries & Druggi | Chan Heng Fai Ambrose | U0 | DOT | CEO | P | 212 | 6.53 | 0 | 33 | 7 | 506 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |